Answers are grounded in this paper and cite their sources.
Case report demonstrates oral and muco-cutaneous ulcer development during methotrexate therapy, highlighting the critical need for proactive monitoring and toxicity management.
In recent years, the use of methotrexate, a commonly prescribed immunosuppressive agent, has gained prominence in the management of various autoimmune disorders and malignancies.However, alongside its therapeutic benefits, methotrexate administration has been associated with several adverse effects.One noteworthy complication is the development of oral ulcers, which can significantly impact patients' quality of life and treatment adherence.This case report presents a detailed examination of a patient who developed oral ulcers subsequent to methotrexate therapy.By analyzing the clinical course, potential mechanisms, and management strategies employed, this report sheds light on the importance of vigilant monitoring and proactive management of methotrexate-induced muco-cutaneous ulcers to ensure optimal patient care.
No takes yet. Share an insight, caveat, or question.
E. et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: